•Diabetes raises ulcerative keratitis risk by 60%, study finds•Surrozen submits IND to FDA for DME therapeutic •GMAC names 2026-2027 international advisory panel •AMA supports formal classification of myopia as a disease•FDA grants IDE approval to Ciliatech for glaucoma implant study •Diabetes raises ulcerative keratitis risk by 60%, study finds•Surrozen submits IND to FDA for DME therapeutic •GMAC names 2026-2027 international advisory panel •AMA supports formal classification of myopia as a disease•FDA grants IDE approval to Ciliatech for glaucoma implant study
HEADLINES
FEATURED
Company remains on track for a Q4 2026 submission; wet AMD IVT implant has the potential for long-term durability and fewer injections.
Earn FREE CE 24/7 with Courses by Eyes On Eyecare
Explore premium-quality, bite-sized courses featuring leading experts like Cecelia Koetting, OD, FAAO, and Cory Lappin, OD, MS, FAAO, and continuing education covering topics from ocular rosacea treatments to retinal disease.
